nulibry (fosdenopterin hydrobromide)Medication DetailsSentynl Therapeutics, Inc.Usage: NULIBRY is indicated for reducing the risk of mortality in patients with molybdenum cofactor deficiency (MoCD) Type A.Medication DetailsDrug Interactions
zokinvy - lonafarnib capsule(Lonafarnib)Medication DetailsSentynl Therapeutics, Inc.Medication Details